pulmonary cryptococcosis
Conditions
Interventions
Confirmed pulmonary cryptococcosis group:Fluconazole
Clinical diagnosis pulmonary cryptococcus group:Fluconazole
Sponsors
Fuzhou General Hospital of Nanjing Military Command
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18-80 years old; 2. First onset, including out-of-hospital and nosocomial infections; 3. Confirmed or clinically diagnosed pulmonary cryptococcosis
Exclusion criteria
Exclusion criteria: 1. HIV patients; 2. Cases with only symptoms of risk factors and/or unexplained fever without typical or new imaging manifestations and serological, microbiological or pathological evidence.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cryptococcal capsular antigen;CT Scan-Chest; | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood routine examination;biochemistry;C-reactive protein;procalcitonin;erythrocyte sedimentation rate;lymphocyte subpopulation; | — |
Countries
China
Contacts
Public ContactLai Guoxiang
The 900th Hospital of the Joint Logistic Support Force
Outcome results
None listed